Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.
<h4>Objective</h4>The etiopathogenesis and risk for development of biliary neoplasia in primary sclerosing cholangitis (PSC) are largely unknown. Microbes or their metabolites have been suggested to play a role. To explore this potential microbial involvement, we evaluated the difference...
Main Authors: | Pedro Pereira, Velma Aho, Johanna Arola, Sonja Boyd, Kalle Jokelainen, Lars Paulin, Petri Auvinen, Martti Färkkilä |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182924&type=printable |
Similar Items
-
PNPLA3 allele frequency has no impact on biliary bile acid composition or disease course in patients with primary sclerosing cholangitis.
by: Martti Färkkilä, et al.
Published: (2022-01-01) -
PNPLA3 allele frequency has no impact on biliary bile acid composition or disease course in patients with primary sclerosing cholangitis
by: Martti Färkkilä, et al.
Published: (2022-01-01) -
Biliary hCGβ Is a Potential Novel Marker for Prediction of Biliary Neoplasia in Primary Sclerosing Cholangitis Patients
by: Hannu Koistinen, et al.
Published: (2021-12-01) -
Surrogate markers of bile duct disease progression in primary sclerosing cholangitis – A prospective study with repeated ERCP examinations
by: Martti Färkkilä, et al.
Published: (2024-10-01) -
Quantitative bile and serum proteomics for the screening and differential diagnosis of primary sclerosing cholangitis.
by: Matilda Holm, et al.
Published: (2022-01-01)